2025 annual financial data
Verrica Pharmaceuticals 2025 Operating margin
Verrica Pharmaceuticals 2025 operating margin with verified reported values.
Direct answer
Operating margin was -33.56%.
Operating income was -11,939,000 USD and net income was -17,886,000 USD.
Operating cash flow was -17,627,000 USD.
Get free Verrica Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 35,577,000 USD
- Operating income
- -11,939,000 USD
- Net income
- -17,886,000 USD
- Operating cash flow
- -17,627,000 USD